Connection

Fengcai Zhu to RNA, Messenger

Back to Details
This is a "connection" page, showing publications Fengcai Zhu has written about RNA, Messenger.
Fengcai Zhu
Connection Strength
0.080
RNA, Messenger
  1. Safety and immunogenicity of the SARS-CoV-2 BNT162b1 mRNA vaccine in younger and older Chinese adults: a randomized, placebo-controlled, double-blind phase 1 study. Nat Med. 2021 06; 27(6):1062-1070.
    View in: PubMed
    Score: 0.080
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.